radiolabeled somatostatin analogue
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for radiolabeled somatostatin analogue, covering 2018-08-14 to 2018-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue [Phase 1, Phase 2]